Related Experiment Videos

Analysis of MTS1/CDK4 in female breast carcinomas

E B Rush1, Z Abouezzi, P I Borgen

  • 1Breast Cancer Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

Cancer Letters
|March 2, 1995
PubMed

Insights

The multiple tumor suppressor gene (MTS1) is not frequently mutated in primary breast tumors. Researchers found no MTS1 gene mutations in 50 breast cancer samples, suggesting it may not be a key factor in breast cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer development involves multiple genetic and environmental factors.
  • The multiple tumor suppressor gene (MTS1) is a candidate gene involved in cell growth regulation through interaction with CDK4.
  • Previous studies indicated high mutation frequencies of MTS1 in various tumors and cell lines.

Purpose of the Study:

  • To investigate the incidence of mutations in the MTS1 gene in primary breast adenocarcinomas.
  • To assess the role of MTS1 gene mutations in breast carcinogenesis.

Main Methods:

  • Analysis of exons 1 and 2 of the MTS1 gene using Polymerase Chain Reaction-Single Strand Conformation Polymorphism (PCR-SSCP).
  • Study included 50 primary breast adenocarcinomas and corresponding normal tissues.
  • Five breast tumor cell lines were also analyzed for MTS1 gene alterations.

Main Results:

  • No mutations were detected in the MTS1 gene within the 50 primary breast tumor samples.
  • One breast tumor cell line exhibited a homozygous deletion of the MTS1 gene.
  • The study found no significant mutation incidence of MTS1 in primary breast tumors.

Conclusions:

  • The MTS1 gene does not appear to be frequently mutated in primary breast tumors.
  • MTS1 gene mutations may not play a significant role in the development of breast cancer.
  • Further research may be needed to explore other genetic factors in breast carcinogenesis.

Related Concept Videos